Page last updated: 2024-10-28

miltefosine and Dysphagia

miltefosine has been researched along with Dysphagia in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research Excerpts

ExcerptRelevanceReference
"Treatment with amphotericin B and miltefosine permitted complete resolution of the lesions and no recurrence during the 18-month follow-up period."1.62Case Report: Progressive Dysphonia and Dysphagia due to Laryngeal Leishmaniasis. ( Bakhos, D; Desoubeaux, G; Lemaignen, A; Renard, L, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Renard, L1
Lemaignen, A1
Desoubeaux, G1
Bakhos, D1

Other Studies

1 other study available for miltefosine and Dysphagia

ArticleYear
Case Report: Progressive Dysphonia and Dysphagia due to Laryngeal Leishmaniasis.
    The American journal of tropical medicine and hygiene, 2021, 06-14, Volume: 105, Issue:2

    Topics: Aged; Amphotericin B; Antiprotozoal Agents; Deglutition Disorders; Diagnosis, Differential; Dysphoni

2021